GOSS Chart
- 52-Week Range: $6.41 - $14.07
- Market Capitalization: $589.17M
- Short Percentage: 0%
- Target Price: $15.70
- Shares Outstanding: 77.12M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
GOSS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Gossamer Bio, Inc. (GOSS) CEO Faheem Hasnain on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha | November 8th
- Gossamer Bio to Host Webcast Announcing its Next Clinical Product Candidates on October 11, 2021Business Wire | October 7th
- Gossamer Bio, Inc. (GOSS) CEO Faheem Hasnain on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha | August 9th
- Gossamer Bio Announces Promotion of Richard Aranda, M.D., to Chief Medical OfficerBusiness Wire | June 21st
Company Info
Website: https://www.gossamerbio.com
Address: 3013 Science Park Road, San Diego, CA, United States, 92121
Sector: Healthcare
Industry: Biotechnology
Full time employees: 185
Address: 3013 Science Park Road, San Diego, CA, United States, 92121
Sector: Healthcare
Industry: Biotechnology
Full time employees: 185
$GOSS choo choo
$GOSS has just been halted from trading.
$GOSS HODLing
and buying more when I can.
$GOSS good place to average up
$GOSS To the moon!!
$GOSS take what we can get
$GOSS can't get enough